Roche: Change in treatment paradigm for DME with faricimab: Evidence from clinical trials and real-world practice
Location: Forum
Date & Time: Thursday, 5 October, 13:30 - 14:30 CEST
Chairperson(s): Ramin Tadayoni FRANCE
Speakers:
Presentations:
R. Tadayoni FRANCE
13:30 Welcome and opening remarks
P. Mitchell AUSTRALIA
13:35 Exploring first-line use with dual Ang-2/VEGF-A inhibition
S. Sadda USA
13:45 Achieving anatomical control
N. Holekamp USA
13:55 Providing extended durability
All Faculty
14:05 Panel discussion
R. Tadayoni FRANCE
14:25 Closing remarks